People news: Targacept, Shire and Appature

Share this article:
Targacept president and CEO J. Donald deBethizy is resigning from the company “for personal considerations” amid a series of pipeline setbacks. A search for a new CEO is underway, said the company, and a separate Office of the Chairman is being established under board chair Mark Skaletsky. Targacept specializes in neuronal nicotinic receptor drugs, but has seen candidates for depression, diabetes and asthma falter or fail over the past year.

Shire director of integrated marketing Bob Harrell is leaving the pharma for a Seattle-based software-as-a-service startup, Appature, which offers a CRM platform for healthcare marketers. Harrell has spent two decades in the drug and healthcare advertising industries, and has worked at Shire since 2004. “Bob has always had a keen sense of where the industry is heading and how technology can be applied to the commercial aspects of our business,” said Shire chairman Matt Emmens.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media